Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma

BMC Cancer

Table 4 Percentage of cell migration capacity values

Time	Control	48 h	72 h
Treatment	% Cell migration capacity
Untreated	94	95.33	96.98
AZ	93.66	90.3	85.87
AZ	-	-	p < 0.01
MS-275	94	42.33	38.56
MS-275	94	p < 0.001	p < 0.001
AZ + MS-275	95	37	26
AZ + MS-275	95	p < 0.001	p < 0.001

Table 4 shows percentage of cell migration capacity values of SH-SY5Y by AZ (40 μM), MS-275 (0.75 μM) and AZ + MS-275 (40 μM + 0.75 μM) treatments (48 h and 72 h)

ISSN: 1471-2407